What is the main business of N&P Global?

The main business activity of N&P Global focuses on wholesale of pharmaceutical goods.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on June 11, 2021.

Where is the headquarters located?

The headquarters is located at: Aleje Jerozolimskie 85, 02-001 Warszawa.

What is the share capital?

The share capital of the company is PLN 5,000 (approx. $1,351).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.

What revenue was generated?

The company reported a revenue of $8,420 in 2024, which is an increase of 95.5% compared to 2023.

No, the company recorded a net loss of $1,750 in 2024. For comparison, in 2023 the loss was $9,436, meaning the company reduced its loss by 82.4%.

What is the largest operating cost?

The largest operating cost category falls under cost of goods and materials sold. This category amounted to $7,876 in 2024, representing 77% of all operating expenses.

N&P Globalsp. z o.o.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2021-06-11

Share capital

5,000.00 PLN

Registered address

Aleje Jerozolimskie 85/21, 02-001 Warszawa, Poland

Financials

Revenue history (in k)

Filing timeliness

No financial statement for 2025 – the filing deadline has passed. 4 of 4 financial statements were filed late (the longest delay 159 days for 2021).

2025not filed
202420/10/2025
202306/08/2024
202218/07/2023
202121/12/2022

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2024.

Results vs industry

Revenue

This companyUSD 8.42kMedianUSD 1.06mAverageUSD 22.40m

Net profit

This companyUSD -1.75kMedianUSD 37.33kAverageUSD 880.24k

Operating costs

This companyUSD 10.17kMedianUSD 922.77kAverageUSD 21.08m

Assets

This companyUSD 12.82kMedianUSD 608.93kAverageUSD 11.85m

Industry

Authorized Representatives

Qiuju Chen – President of the Management Board

Manner of representation

Each member of the management board is authorized to make declarations on behalf of the company independently.

Ownership

Owner	Shares	Share value	Stake
Qiuju Chenage 48	99	$1,337.12	99%
Others	1	$13.51	1%

Beneficial owners

Person	Rights

Bank accounts

Registered as a VAT taxpayer on 2021-09-06.

PKO Bank Polski
66 1020 1055 0000 9902 0504 0979

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name	Revenue	Website
Vorwarts Pharmasp. z o.o.	$210,138.62	vorwartspharma.pl
Black & Whitesp. z o.o.	$154,866.36	polonus.pl
Osteoprofsp. z o.o.	$72,065.80	osteoprof.pl
THC PharmaS.A.	$39,093.70	thc-pharma.pl
EDGE Pharmasp. z o.o.	$19,855.64	edgepharma.eu
Arcade Internationalsp. z o.o.	$17,817.26	arcade-int.pl
Filicosp. z o.o.	$11,710.75	filico.eu
Get Ready Wheelchairssp. z o.o.	$9,842.54	getreadywheelchairs.com
Jacek Waksmundzki Trust 2S.K.A.	$5,769.53	trust.pl
Optimedussp. z o.o.	$1.00	optimedus.pl